CN1615121A - 掩盖味道的包衣组合物 - Google Patents

掩盖味道的包衣组合物 Download PDF

Info

Publication number
CN1615121A
CN1615121A CNA998165883A CN99816588A CN1615121A CN 1615121 A CN1615121 A CN 1615121A CN A998165883 A CNA998165883 A CN A998165883A CN 99816588 A CN99816588 A CN 99816588A CN 1615121 A CN1615121 A CN 1615121A
Authority
CN
China
Prior art keywords
compositions
dry weight
film forming
content
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA998165883A
Other languages
English (en)
Chinese (zh)
Inventor
G·慕克吉
M·库马尔
H·森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CN1615121A publication Critical patent/CN1615121A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA998165883A 1999-03-19 1999-10-26 掩盖味道的包衣组合物 Pending CN1615121A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN454/DEL/99 1999-03-19
IN454DE1999 IN191482B (ja) 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
CN1615121A true CN1615121A (zh) 2005-05-11

Family

ID=11089863

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA998165883A Pending CN1615121A (zh) 1999-03-19 1999-10-26 掩盖味道的包衣组合物

Country Status (7)

Country Link
EP (1) EP1235556A4 (ja)
CN (1) CN1615121A (ja)
AU (1) AU6224699A (ja)
BR (1) BR9917219A (ja)
IN (1) IN191482B (ja)
WO (1) WO2000056266A2 (ja)
ZA (1) ZA200007724B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191239B (ja) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
CA2457100A1 (en) * 2001-08-01 2003-02-13 Bristol-Myers Squibb Company Taste masking composition
SI1476138T1 (sl) 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
AU648574B2 (en) * 1990-07-20 1994-04-28 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
ES2174849T3 (es) * 1992-06-04 2002-11-16 Smithkline Beecham Corp Composiciones farmaceuticas con sabor agradable.
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen

Also Published As

Publication number Publication date
IN191482B (ja) 2003-12-06
AU6224699A (en) 2000-10-09
WO2000056266A3 (en) 2002-07-04
WO2000056266A2 (en) 2000-09-28
EP1235556A4 (en) 2003-07-16
ZA200007724B (en) 2002-06-12
EP1235556A2 (en) 2002-09-04
BR9917219A (pt) 2002-04-23

Similar Documents

Publication Publication Date Title
KR101752014B1 (ko) 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물
JP3015105B2 (ja) 粉末被覆経口投与剤形
JP5808670B2 (ja) 弱塩基性薬物を含む組成物及び徐放性剤形
US6426091B1 (en) Sustained-release theophylline tablet
KR101489401B1 (ko) 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
JP5878022B2 (ja) 抗コリン薬を具える放出制御組成物
CN101977593B (zh) 包含弱碱性药物以及有机酸的给药系统
CN1244119A (zh) 迅速释放和掩蔽味觉的药物剂型
CN1384740A (zh) 含有曲马朵糖精盐的持续释放给药剂型
IE53543B1 (en) New oral dipyridamole preparations
US20070286903A1 (en) Composition and method for taste masking
CN1178659C (zh) 控释活性化合物的药物制剂
CN1161112C (zh) 含氯雷他定和伪麻黄碱的药物胶囊组合物
CN102046155A (zh) 包含多颗粒的具有双重释放特性的固体口服剂型
WO2003053420A1 (en) Multiple-pulse extended release formulations of clindamycin
CN103402501A (zh) 调节释放的苯并咪唑制剂
JPH09323926A (ja) バルプロ酸ナトリウムの徐放性錠剤
US20070092568A1 (en) Galantamine compositions
JP2001500150A (ja) ［Ｒ―（Ｚ）］―α―（メトキシイミノ）―α―（１―アザビシクロ［２．２．２］オクト―３―イル）アセトニトリル一塩酸塩の制御放出投与形態
CN1615121A (zh) 掩盖味道的包衣组合物
CA2560995A1 (en) Controlled release dosage for gaba receptor agonist
SK286865B6 (sk) Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
ZA200608190B (en) Controleld release dosage for GABA receptor antagonist
WO2011040195A1 (ja) 不快味マスキング粒子及びこれを含有する経口製剤
JP5919173B2 (ja) 徐放性塩酸アンブロキソール口腔内崩壊錠

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication